Trastuzumab deruxtecan Plus Pertuzumab Approved in EU for First-Line HER2-Positive Metastatic Breast Cancer
Jim Weiss: Make It Happen
Ziihera Plus Chemotherapy Improves Overall Survival in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma
Pashtoon Kasi: Lessons from the NEST Phase 2 Trial in Colon Cancer
By Women, for Women: The Untold Stories at the Roots of Oncology
HUTCHMED Reports Positive Phase 3 SANOVO Results for Savolitinib Plus Osimertinib in EGFR-Mutated NSCLC
An Appeal for Solidarity, Compassion, and Support for Nepal’s Ongoing Rescue and Recovery Efforts
The Win-Win Imperative: A Global Call to Make High-Value Cancer Care Affordable
The WAHO ASH Highlights and Insights 2027, organized by the Wisconsin Association of Hematology and Oncology (WAHO), will take place on February 27, 2027, from 7:00 AM to 4:00 PM CST, at The Madison Concourse Hotel in Madison, Wisconsin. The one-day in-person programme is designed for oncology professionals who want a focused review of the […]
